共 58 条
[1]
Angeli F(2018)PK/PD evaluation of fimasartan for the treatment of hypertension current evidences and future perspectives Expert Opin Drug Metab Toxicol 14 533-541
[2]
Arishiro K(2007)Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits J Am Coll Cardiol 49 1482-1489
[3]
Chi YH(2013)Pharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist Biol Pharm Bull 36 1208-1215
[4]
Choi ET(2005)Matrix metalloproteinase-9 modulation by resident arterial cells is responsible for injury-induced accelerated atherosclerotic plaque development in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 25 1020-1025
[5]
Dimayuga PC(2011)Enhanced neointima formation following arterial injury in immune deficient Rag-1−/− mice is attenuated by adoptive transfer of CD8 T cells PLoS One 6 e20214-523
[6]
George J(2012)Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques Atherosclerosis 222 519-519
[7]
Hansson GK(2006)The immune response in atherosclerosis: a double-edged sword Nat Rev Immunol 6 508-104
[8]
Libby P(1999)Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms Circulation 99 96-R216
[9]
Henderson EL(2009)Regulation of T-cell function by endogenously produced angiotensin II Am J Physiol Regul Integr Comp Physiol 296 R208-2065
[10]
Hoch NE(2004)Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model Circulation 110 2060-904